


For Subqutaneous Injection
Composition: Tirzepatide
Dosage: 5 mg/vial
Unit: 2 mL Vial
Form: Lyophilized Powder
Manufactured by Dragon Pharma
Laboratory Test: View Lab Report
Name: Dragozepide
Active Life: Approximately 5 days
Drug Class: Dual GIP and GLP-1 receptor agonist
Detection Time: Not applicable as it is not commonly included in standard drug testing protocols
Chemical Structure: C225H348N48O68
Common Doses: Starts at 2.5 mg once weekly; titrated up to 5 mg, 10 mg, or 15 mg once weekly based on clinical response and tolerability
Blood pressure: May help reduce blood pressure in patients
Acne: No
Water retention: Minimal to none
Aromatisation: No
Liver toxicity: No direct hepatotoxicity reported, but should be used with caution in patients with hepatic impairment
Decrease HPTA function: No
British Dragon store offers Dragozepide by Dragon Pharma, a high-purity GLP-1 receptor agonist research peptide designed for scientific and laboratory studies. This research compound has been examined for its role in metabolic studies, glucose regulation, and peptide-based research applications.
Dragozepide, crafted by Dragon Pharma, is a research-grade GLP-1 receptor agonist peptide available in a 2 mL vial in lyophilized powder form. This peptide-based compound is studied in scientific research exploring GLP-1 receptor activation, metabolic regulation, and peptide interactions.
As a GLP-1 research peptide, Dragozepide is analyzed for its impact on energy balance, receptor pathways, and glucose metabolism in controlled laboratory settings.
Dragozepide has been examined in various scientific studies for its potential effects on:
✅ GLP-1 receptor activation & metabolic function
✅ Peptide-based research on glucose metabolism
✅ Energy balance & appetite regulation studies
✅ GLP-1 pathway interactions in laboratory settings
Although Dragozepide is not a performance-enhancing substance, it is studied in metabolic research for its role in GLP-1 receptor activation. In hypothetical research applications, a 2 mL vial may be used over several weeks, with dosages adjusted based on laboratory study parameters.
Some research suggests mild and temporary effects such as:
✔ Nausea or mild digestive discomfort
✔ Injection site irritation
✔ Changes in appetite modulation
✔ Store in a cool, dry place away from direct sunlight
✔ Reconstitute using bacteriostatic water following standard peptide protocols
✔ For scientific research use only
✔ High-Purity GLP-1 Research Peptide
✔ Manufactured Under Strict Laboratory Conditions
✔ Verified Lab-Tested Quality
✔ Secure Ordering & Fast USA Shipping
⚠️ For research use only. Not for human consumption.
⚠️ This product is not approved for medical use, diagnosis, or treatment.
⚠️ Not affiliated with or manufactured by any pharmaceutical company.
Please log in to write Dragozepide review.
For Subcutaneous Injection
Composition: Somatropin (r-hGH)
Dosage: 10 IU/vial
Unit: 1 Kit [10 Vials]
Form: Powder
Manufactured by Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection
Composition: Human Chorionic Gonadotropin
Dosage: 2500 IUs/vial
Unit: 2 mL Multidose Vial + 1 Amp Solvent
Form: Powder
Manufactured by Dragon Pharma
Laboratory Test: View Lab Report
For Subqutaneous Injection
Composition: Thymosin Beta-4
Dosage: 5 mg/vial
Form: Powder
Unit: 2 mL Vial
Manufactured by Dragon Pharma
Laboratory Test: View Lab Report
For Subqutaneous Injection
Composition: Semaglutide
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Manufactured by Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection
Composition: Human Chorionic Gonadotropin
Dosage: 5000 IUs/vial
Unit: 2 mL Multidose Vial + 1 Amp Solvent
Form: Powder
Manufactured by Dragon Pharma
Laboratory Test: View Lab Report
Sep 13, 2024 (18:10)
I've been on Dragozepide from Dragon Pharma for three months now, and I couldn't be happier. My blood sugar is better than ever, and I'm consistently losing weight. The quality and efficacy of this product are impressive.